Interaction of ACE and CYP11B2 Genes on Blood Pressure Response to Hydrochlorothiazide in Han Chinese Hypertensive Patients

REFERENCES

• Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365: 217–223.
   PubMed Web of Science ®Google Scholar
• Reynolds K, Gu D Muntner P Kusek,JW Chen J, Wu X, Duan X, Chen CS, Klag MJ, Whelton PK, He J. A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol 2007; 18:1928–1935.
   PubMed Web of Science ®Google Scholar
• Inoue R, Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hirose T, Hara A, Hoshi H, Hashimoto J, Totsune K, Satoh H, Kondo Y, Imai Y. Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure the ohasama study. Am J Hypertens 2007;20: 1125–1131.
   PubMed Web of Science ®Google Scholar
• Elliott WJ. Cardiovascular events in hypertension trials of angiotensin-converting enzyme inhibitors. J Clin Hypertens (Greenwich) 2005; 7:2–4.
   Google Scholar
• Schultz HD, Li YL, Ding Y. Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension 2007; 50:6–13.
   PubMed Web of Science ®Google Scholar
• Paoletti E, Bellino D, Amidone M, Rolla D, Cannella G. Relationship between arterial hypertension and renal damage in chronic kidney disease: insights from ABPM. J Nephrol 2006;19:778–782.
   PubMed Web of Science ®Google Scholar
• Schelleman H, Klungel OH, Kromhout D, de Boer A, Stricker BH, Verschuren WM. Prevalence and determinants of undertreatment of hypertension in the Netherlands. J Hum Hypertens 2004a;18:317–324.
   PubMed Web of Science ®Google Scholar
• Suonsyrja T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Donner K, Strandberg T, Tikkanen I, Tilvis R, Pentikainen PJ, Kontula K, Hiltunen TP. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study. J Hypertens 2008;26: 1250–1256.
   PubMed Web of Science ®Google Scholar
• Casiglia E, Tikhonoff V, Schiavon L, Guglielmi F, Pagnin E, Bascelli A, Basso G, Mazza A, Martini B, Bolzon M, Guidotti F, Caffi S, Rizzato E, Pessina AC. Skinfold thickness and blood pressure across C-344T polymorphism of CYP11B2 gene. J Hypertens 2007;25:1828–1833.
   PubMed Web of Science ®Google Scholar
• Cheng X, Xu G. Association between aldosterone synthase CYP11B2 polymorphism and essential hypertension in Chinese: a meta-analysis. Kidney Blood Press Res 2009;32:128–140.
   PubMed Web of Science ®Google Scholar
• Eisenmann JC, Sarzynski MA, Glenn K, Rothschild M, Heelan KA. ACE I/D genotype, adiposity, and blood pressure in children. Cardiovasc Diabetol 2009; 8:14.
   PubMedGoogle Scholar
• Niu W, Qi Y, Hou S, Zhai X, Zhou W, Qiu C. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: The Fangshan Study. J Hypertens 2009;27: 1384–1391.
   PubMed Web of Science ®Google Scholar
• Arnett DK, Claas SA, Lynch AI.. Has pharmacogenetics brought us closer to ‘personalized medicine’ for initial drug treatment of hypertension? Curr Opin Cardiol 2009;24:333–339.
   PubMed Web of Science ®Google Scholar
• Johnson JA, Boerwinkle E, Zineh I, Chapman AB, Bailey K, Cooper-DeHoff RM, Gums J, Curry RW, Gong Y, Beitelshees AL, Schwartz G, Turner ST. Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. Am Heart J 2009;157:442–449.
   PubMed Web of Science ®Google Scholar
• Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460–2470.
   PubMed Web of Science ®Google Scholar
• Schelleman H, Stricker BH, De Boer A, Kroon AA, Verschuren MW, Van Duijn CM, Psaty BM, Klungel OH. Drug-gene interactions between genetic polymorphisms and antihypertensive therapy. Drugs 2004b;64:1801–1816.
   PubMed Web of Science ®Google Scholar
• Sciarrone MT, Stella P, Barlassina C, Manunta P, Lanzani C, Bianchi G, Cusi D. ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 2003;41:398–403.
   PubMed Web of Science ®Google Scholar
• Stavroulakis GA, Makris TK, Krespi PG, Hatzizacharias AN, Gialeraki AE, Anastasiadis G, Triposkiadis P, Kyriakidis M. Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism. Cardiovasc Drugs Ther 2000;14:427–432.
   PubMed Web of Science ®Google Scholar
• Schwartz GL, Turner ST, Chapman AB, Boerwinkle E. Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int 2002;62:1718–1723.
   PubMed Web of Science ®Google Scholar
• Schelleman H, Stricker BH, Verschuren WM, de Boer A, Kroon AA, de Leeuw PW, Kromhout D, Klungel OH. Interactions between five candidate genes and antihypertensive drug therapy on blood pressure. Pharmacogenomics J 2006; 6:22–26.
   PubMed Web of Science ®Google Scholar
• Gu D, Ge D, He J. Haplotypic analyses of the aldosterone synthase gene CYP11B2 associated with stage-2 hypertension in northern Han Chinese. Clin Genet 2004;66:409–416.
   PubMed Web of Science ®Google Scholar
• Yu HM, Lin SG, Liu GZ, Zhang YQ, Ma WJ, Deng CY. Associations between CYP11B2 gene polymorphisms and the response to angiotensin-converting enzyme inhibitors. Clin Pharmacol Ther 2006;79:581–589.
   PubMed Web of Science ®Google Scholar
• Frazier L, Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic. Pharmacogenomics J 2004;4:17–23.
   PubMed Web of Science ®Google Scholar
• Ekinci EI, Thomas G, Thomas D, Johnson C, Macisaac RJ, Houlihan CA, Finch S, Panagiotopoulos S, O'Callaghan C, Jerums G. Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake. Diabetes Care 2009;32:1398–1403.
   PubMed Web of Science ®Google Scholar